Pharmaceutical

Holista Colltech enters joint venture with SCC for ovin...

Partnership will support funding, development and operation of collagen produc...

Emcure Pharmaceuticals posts ₹9,204 crore revenue in FY...

Emcure Pharmaceuticals reports growth across domestic and international business...

Venus Remedies receives Argentina approval for Ceftriax...

Venus Remedies secures marketing authorisation for Ceftriaxone in Argentina, ta...

Daiichi Sankyo and Waiv partner for ADC biomarkers

Waiv will use its computational pathology platform to work with early phase data...

Halozyme and Oruka sign agreement for Hypercon technology

Oruka has licensed the Halozyme technology for use with its lead programme, ORKA...

B&R showcases automation and vision solutions for packa...

ABB’s Machine Automation division introduces transport, simulation and colour v...

Neuland Laboratories partners with LIR Life Sciences fo...

Collaboration focuses on CPP platform development for obesity treatment program...

US FDA launches pilot for one-day inspectional assessme...

Initiative aims to support risk-based oversight and expand inspection coverage ...

Citius raises $36.5m for Lymphir commercialisation

The therapy is approved by the US Food and Drug Administration (FDA) for adult p...

MSD concludes Terns acquisition to expand CML pipeline

Following a successful tender offer and subsequent merger, the companies announc...

Gujarat’s bet on Jambusar 

Between the Gulf of Khambhat and the Narmada, India is staking 3,920 crores on ...

Haroli: Himachal’s next pharma play 

In Haroli, a quiet industrial location is being positioned at the centre of Ind...

India’s next pharma powerhouses

India’s pharma growth is increasingly being shaped not just by companies, but b...

The next wave 

India’s next pharma leap is being built from the ground up, through a new gener...

Holista executes binding JV for collie collagen facility

Holista Colltech is pleased to announce that it has entered into a binding Join...

Genome Valley: Aligning with what comes next 

For years now, the Indian pharma industry has been talking about moving beyond ...